Latest California Healthline Stories
Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?
Biologic drugs, made from living organisms, and the cheaper biosimilar drugs that mimic them are more complex than chemical drugs and their generic counterparts. The Food and Drug Administration says biosimilars are as safe and effective as the biologics, and doctors agree — but they are cautious about changing the treatment regimen of patients doing well.
At an Overrun ICU, ‘the Problem Is We Are Running Out of Hallways’
Billings Clinic in Montana is past the tipping point as it looks for places to add intensive care unit beds and is on the cusp of rationing care to deal with the surge of sick covid patients in a state with significant anti-vaccination sentiment.
Congress Cites KHN Investigation in Probe of National Academies
The House oversight committee is requesting conflict-of-interest disclosure forms from a National Academies committee studying organ transplants. KHN previously reported on apparent conflicts among members of a committee studying drug waste.
Covid-Overwhelmed Hospitals Postpone Cancer Care and Other Treatment
Patients with advanced cancer and heart disease are among those who have had to have surgeries and other treatments delayed and rescheduled as a high number of critically ill, unvaccinated covid patients strain the medical system.
KHN’s ‘What the Health?’: Much Ado About Drug Prices
Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall — moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure’s health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interview’s KHN’s Phil Galewitz about the latest KHN-NPR “Bill of the Month” installment, about two similar jaw surgeries with very different price tags.
Journalists Explain Ramifications of Theranos Trial and Texas’ New Abortion Law
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Florida Spine Surgeon and Device Company Owner Charged in Kickback Scheme
Dr. Kingsley R. Chin and SpineFrontier were the subject of a recent KHN “Spinal Tap” investigation.
Lack of a Vaccine Mandate Becomes Competitive Advantage in Hospital Staffing Wars
After months of burnout from the pandemic, hospitals are scrambling to fill nursing and other jobs. Some administrators, particularly in rural areas, are afraid to implement vaccine mandates that alienate their short-handed staffs.
Jaw Surgery Takes a $27,119 Bite out of One Man’s Budget
A Seattle patient discovers the hard way that you can still hit a lifetime limit for certain types of care. And health plans can vary a lot from one job to the next, even if the insurer is the same.
KHN’s ‘What the Health?’: Vaccine Approval Moves the Needle on Covid
The FDA’s formal approval of the first vaccine to prevent covid-19 may or may not prompt doubters to go out and get shots, but it has clearly prompted employers to make vaccination a work requirement. Meanwhile, moderates and liberals in the U.S. House put aside their differences long enough to keep a giant social-spending bill on track, at least for now. Joanne Kenen of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest their favorite health policy stories of the week they think you should read, too.